ByMyCell
PrivateLast Round
Accelerator
May 1, 2025
Total Funding Raised
$320,000
Company Overview
ByMyCell operates in Healthcare & Life Sciences and is based in Ribeirão Preto. Its latest recorded funding round was an Accelerator round in May 2025.
ByMyCell is a biotechnology company that provides genomic sequencing and data analysis services for the agricultural and research sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring, Cloud Infrastructure, Business Intelligence
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ByMyCell Comparables
Compare ByMyCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GoSolos | 84% | |
| GenomaA Biotech | 79% | |
| bioMérieux | 78% |
For institutional investors. Book with your work email.
ByMyCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 1, 2025 | ||||
| Seed | Jan 31, 2024 | ||||
| Grant | Aug 27, 2023 | ||||
| Angel | Mar 31, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ByMyCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 31% MoM, reaching 1.8K.
- Apr 22, 2026
Monthly visitors increased 259% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
ByMyCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ByMyCell's valuation, stock price, and market status.
Is ByMyCell a public or private company?
ByMyCell is a private company.
What is the current stock price of ByMyCell?
ByMyCell is a private company, so its shares have no public market price. Caplight tracks ByMyCell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ByMyCell worth (valuation)?
Valuation information for ByMyCell is not publicly available.
Can I buy ByMyCell stock?
ByMyCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ByMyCell's last funding round?
ByMyCell's most recent funding round was Accelerator on May 1, 2025.
Who are the main investors in ByMyCell?
Key investors in ByMyCell include FAPESP.
Will ByMyCell IPO soon?
No public IPO plans have been announced for ByMyCell.
How can I track ByMyCell secondary market activity?
Caplight tracks bids, offers, and trades in ByMyCell's shares on secondary markets.